Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Felina Anić"'
Autor:
Felina Anić, Srđan Novak
Publikováno v:
Reumatizam
Volume 65
Issue suppl.1
Volume 65
Issue suppl.1
Assessment of disease activity and accumulated damage in systemic lupus erythematosus (SLE) patients is important for the successful treatment management. In 1996 Systemic Lupus International Collaborating Clinics (SLICC)/ American College of Rheumat
Publikováno v:
Croatian Medical Journal
Volume 55
Issue 5
Croatian medical journal
Volume 55
Issue 5
Croatian medical journal
Aim. To determine the prevalence of American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) classification criteria among systemic lupus erythematosus (SLE) patients ; to determine dis¬ease activity and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4bfcefee493ce1ebac3ecad4d1c21b9
https://www.bib.irb.hr/812958
https://www.bib.irb.hr/812958
Autor:
Katarina, Šarič, Adriana, Šemper, Felina, Anić, Tatjana, Zekić, Mladen, Defranceschi, Srđan, Novak
Publikováno v:
Liječnički vjesnik
Volume 136
Issue 9-10
Volume 136
Issue 9-10
Temporalni arteritis kronični je vaskulitis velikih i srednje velikih arterija, koji najčešće zahvaća ogranke karotidnih arterija. Početni su simptomi glavobolja, slabost i umor. U kasnijem tijeku javljaju se osjetljivost vlasišta, nedostatak
Publikováno v:
Reumatizam
Volume 60
Issue 2
Volume 60
Issue 2
Publikováno v:
Reumatizam
Volume 60
Issue 2
Volume 60
Issue 2
Publikováno v:
Reumatizam
Volume 60
Issue 2
Volume 60
Issue 2
Autor:
Felina Anić, Srđan Novak
Publikováno v:
Medicina Fluminensis : Medicina Fluminensis
Volume 48
Issue 1
Volume 48
Issue 1
Sustavni eritemski lupus (SLE) kronična je upalna autoimuna bolest. Najčešće obolijevaju žene fertilne dobi, pa se međusoban utjecaj trudnoće i sustavnog eritemskog lupusa nameće kao značajan klinički i terapijski problem. Hormonski i imuni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::658af80b49be05667ff35b52b8b636a0
https://repository.medri.uniri.hr/islandora/object/medri:1042/datastream/FILE0
https://repository.medri.uniri.hr/islandora/object/medri:1042/datastream/FILE0
Publikováno v:
Reumatizam
Volume 55
Issue 2
Volume 55
Issue 2
Autor:
Felina Anić
Publikováno v:
Reumatizam
Volume 55
Issue 2
Volume 55
Issue 2
Publikováno v:
ResearcherID
Anti-tumour necrosis factor (TNF) monoclonal antibodies have become an invaluable treatment against chronic inflammatory diseases such as rheumatoid arthritis (RA). However, due to increased risk of opportunistic infections, patients receiving anti-T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55801e6edcbb09b1a9a7a9755ca46f18
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000329085600022&KeyUID=WOS:000329085600022
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000329085600022&KeyUID=WOS:000329085600022